<!DOCTYPE html>
<html lang="zh-TW" class="scroll-pt-24">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Semaglutide (索馬魯肽) 深度解析：從減重到全身器官保護的實證醫學</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/js/all.min.js"></script>
    <script>
        tailwind.config = {
            theme: {
                extend: {
                    colors: {
                        primary: '#0F4C81', // 經典藍
                        primaryDark: '#0a365c',
                        secondary: '#D4AF37', // 質感金
                        accent: '#F0F9FF', // 淺藍背景
                        success: '#10B981',
                        textMain: '#2D3748',
                        textLight: '#718096'
                    },
                    fontFamily: {
                        sans: ['"Noto Sans TC"', 'sans-serif'],
                        serif: ['"Noto Serif TC"', 'serif'],
                    }
                }
            }
        }
    </script>
    <link href="https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@300;400;500;700&family=Noto+Serif+TC:wght@700&display=swap" rel="stylesheet">
    <style>
        body { font-family: 'Noto Sans TC', sans-serif; }
        h1, h2, h3 { font-family: 'Noto Serif TC', serif; }
        .gradient-bg { background: linear-gradient(135deg, #0F4C81 0%, #1e6091 100%); }
        .card-hover { transition: all 0.3s ease; }
        .card-hover:hover { transform: translateY(-5px); box-shadow: 0 10px 20px rgba(0,0,0,0.1); }
        .chart-bar { transition: width 1s ease-out; }
        /* Smooth scrolling for anchor links */
        html { scroll-behavior: smooth; }
    </style>
</head>
<body class="text-textMain bg-gray-50 antialiased">

    <!-- 導覽列 -->
    <nav class="fixed w-full bg-white/95 backdrop-blur-md shadow-md z-50 transition-all duration-300">
        <div class="container mx-auto px-4 lg:px-8 py-3 flex justify-between items-center">
            <div class="flex items-center gap-3">
                <div class="w-10 h-10 bg-primary text-white rounded-lg flex items-center justify-center text-xl shadow-lg">
                    <i class="fa-solid fa-dna"></i>
                </div>
                <div>
                    <div class="text-lg font-bold text-primary leading-none">代謝醫學</div>
                    <div class="text-xs text-textLight tracking-widest">實證衛教網</div>
                </div>
            </div>
            
            <!-- Desktop Menu -->
            <div class="hidden lg:flex gap-8 text-sm font-medium text-gray-600">
                <a href="#mechanism" class="hover:text-primary transition py-2 border-b-2 border-transparent hover:border-secondary">作用機轉</a>
                <a href="#weight" class="hover:text-primary transition py-2 border-b-2 border-transparent hover:border-secondary">減重成效</a>
                <a href="#cv-renal" class="hover:text-primary transition py-2 border-b-2 border-transparent hover:border-secondary">心腎保護</a>
                <a href="#comparison" class="hover:text-primary transition py-2 border-b-2 border-transparent hover:border-secondary">藥物比較表</a>
                <a href="#safety" class="hover:text-primary transition py-2 border-b-2 border-transparent hover:border-secondary">副作用管理</a>
            </div>

            <button class="bg-secondary text-white px-6 py-2 rounded-full text-sm font-bold hover:bg-yellow-600 transition shadow-md">
                線上諮詢
            </button>
        </div>
    </nav>

    <!-- 主視覺 Hero Section -->
    <header class="relative pt-32 pb-20 lg:pt-48 lg:pb-32 overflow-hidden bg-white">
        <!-- Background Elements -->
        <div class="absolute top-0 right-0 w-1/2 h-full bg-accent opacity-50 rounded-bl-[100px] -z-10"></div>
        <div class="absolute bottom-0 left-0 w-64 h-64 bg-yellow-50 rounded-full blur-3xl -z-10"></div>

        <div class="container mx-auto px-4 lg:px-8 flex flex-col lg:flex-row items-center gap-16">
            <div class="lg:w-1/2 space-y-6">
                <div class="inline-flex items-center gap-2 bg-blue-50 text-primary px-4 py-1 rounded-full text-xs font-bold tracking-wide uppercase border border-blue-100">
                    <i class="fa-solid fa-check-circle"></i> GLP-1 RA 療法新標竿
                </div>
                <h1 class="text-4xl lg:text-6xl font-bold leading-tight text-gray-900">
                    Semaglutide<br>
                    <span class="text-primary">不只是減重，<br>更是全身代謝的修復</span>
                </h1>
                <p class="text-lg text-gray-600 leading-relaxed text-justify">
                    Semaglutide (索馬魯肽) 是模擬人體天然荷爾蒙 GLP-1 的長效製劑。除了卓越的體重管理效果外，近期發表於《新英格蘭醫學期刊》(NEJM) 的多項大型臨床試驗證實，它能顯著降低<strong>心血管死亡風險</strong>、延緩<strong>慢性腎臟病</strong>進程，並改善<strong>代謝性脂肪肝</strong>，重新定義了慢性病治療的標準。
                </p>
                <div class="flex flex-wrap gap-4 pt-4">
                    <a href="#weight" class="px-8 py-3.5 bg-primary text-white rounded-lg font-medium shadow-lg hover:bg-primaryDark transition flex items-center gap-2">
                        <i class="fa-solid fa-chart-line"></i> 查看減重數據
                    </a>
                    <a href="#comparison" class="px-8 py-3.5 bg-white text-primary border-2 border-primary rounded-lg font-medium hover:bg-blue-50 transition flex items-center gap-2">
                        <i class="fa-solid fa-scale-balanced"></i> 藥物比較表
                    </a>
                </div>
            </div>
            
            <div class="lg:w-1/2 relative">
                <!-- Data Visualization Card in Hero -->
                <div class="relative bg-white p-8 rounded-2xl shadow-2xl border border-gray-100 max-w-md mx-auto transform rotate-2 hover:rotate-0 transition duration-500">
                    <div class="absolute -top-4 -left-4 w-16 h-16 bg-secondary rounded-full flex items-center justify-center text-white text-2xl shadow-lg z-20">
                        <i class="fa-solid fa-shield-heart"></i>
                    </div>
                    <h3 class="text-xl font-bold text-gray-800 mb-6 text-center border-b pb-4">全方位器官保護實證</h3>
                    
                    <div class="space-y-6">
                        <!-- Stat 1 -->
                        <div class="flex items-center gap-4">
                            <div class="w-12 h-12 rounded-full bg-red-50 flex items-center justify-center text-red-500 text-xl">
                                <i class="fa-solid fa-heart-pulse"></i>
                            </div>
                            <div class="flex-1">
                                <div class="flex justify-between text-sm mb-1">
                                    <span class="font-bold text-gray-700">心血管風險降低</span>
                                    <span class="font-bold text-red-600">20%</span>
                                </div>
                                <div class="w-full bg-gray-100 rounded-full h-2">
                                    <div class="bg-red-500 h-2 rounded-full" style="width: 20%"></div>
                                </div>
                                <p class="text-xs text-gray-400 mt-1">來源: SELECT Trial (NEJM 2023)</p>
                            </div>
                        </div>

                        <!-- Stat 2 -->
                        <div class="flex items-center gap-4">
                            <div class="w-12 h-12 rounded-full bg-blue-50 flex items-center justify-center text-blue-500 text-xl">
                                <i class="fa-solid fa-kidneys"></i>
                            </div>
                            <div class="flex-1">
                                <div class="flex justify-between text-sm mb-1">
                                    <span class="font-bold text-gray-700">腎病惡化風險降低</span>
                                    <span class="font-bold text-blue-600">24%</span>
                                </div>
                                <div class="w-full bg-gray-100 rounded-full h-2">
                                    <div class="bg-blue-500 h-2 rounded-full" style="width: 24%"></div>
                                </div>
                                <p class="text-xs text-gray-400 mt-1">來源: FLOW Trial (NEJM 2024)</p>
                            </div>
                        </div>

                        <!-- Stat 3 -->
                        <div class="flex items-center gap-4">
                            <div class="w-12 h-12 rounded-full bg-green-50 flex items-center justify-center text-green-500 text-xl">
                                <i class="fa-solid fa-weight-scale"></i>
                            </div>
                            <div class="flex-1">
                                <div class="flex justify-between text-sm mb-1">
                                    <span class="font-bold text-gray-700">體重減輕平均值</span>
                                    <span class="font-bold text-green-600">~15%</span>
                                </div>
                                <div class="w-full bg-gray-100 rounded-full h-2">
                                    <div class="bg-green-500 h-2 rounded-full" style="width: 75%"></div>
                                </div>
                                <p class="text-xs text-gray-400 mt-1">來源: STEP 1 Trial (NEJM 2021)</p>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- 1. 機轉詳解 (Mechanism) -->
    <section id="mechanism" class="py-20 bg-white">
        <div class="container mx-auto px-4 lg:px-8">
            <div class="flex flex-col lg:flex-row gap-12">
                <div class="lg:w-1/3">
                    <h2 class="text-3xl font-bold text-primary mb-6 border-l-8 border-secondary pl-4">多重作用機轉：<br>為何效果如此顯著？</h2>
                    <p class="text-gray-600 mb-6 leading-relaxed">
                        GLP-1 (Glucagon-like peptide-1) 是一種腸道荷爾蒙。Semaglutide 透過修飾結構，使其半衰期延長至一週，並能更有效地作用於全身各處的 GLP-1 受體。
                    </p>
                    <div class="bg-blue-50 p-6 rounded-xl border border-blue-100">
                        <h4 class="font-bold text-primary mb-2"><i class="fa-solid fa-lightbulb text-secondary mr-2"></i>關鍵概念：中樞調控</h4>
                        <p class="text-sm text-gray-600">
                            不同於傳統減肥藥僅作用於腸胃，Semaglutide 能穿過血腦屏障 (Blood-Brain Barrier)，直接作用於下視丘的食慾控制中心，從源頭降低對食物的渴望 (Cravings)。
                        </p>
                    </div>
                </div>
                
                <div class="lg:w-2/3 grid md:grid-cols-2 gap-6">
                    <!-- Organ 1 -->
                    <div class="card-hover bg-white p-6 rounded-xl shadow-md border border-gray-100">
                        <div class="text-4xl text-primary mb-4"><i class="fa-solid fa-brain"></i></div>
                        <h3 class="text-xl font-bold text-gray-800 mb-2">大腦 (Brain)</h3>
                        <ul class="text-sm text-gray-600 space-y-2 list-disc list-inside">
                            <li>增加飽足感訊號</li>
                            <li>降低飢餓感訊號</li>
                            <li><strong>減少對高糖高油食物的渴望 (Reward System)</strong></li>
                        </ul>
                    </div>
                    <!-- Organ 2 -->
                    <div class="card-hover bg-white p-6 rounded-xl shadow-md border border-gray-100">
                        <div class="text-4xl text-rose-500 mb-4"><i class="fa-solid fa-utensils"></i></div>
                        <h3 class="text-xl font-bold text-gray-800 mb-2">胃部 (Stomach)</h3>
                        <ul class="text-sm text-gray-600 space-y-2 list-disc list-inside">
                            <li>延緩胃排空速度</li>
                            <li>延長餐後飽足時間</li>
                            <li>平穩餐後血糖波動</li>
                        </ul>
                    </div>
                    <!-- Organ 3 -->
                    <div class="card-hover bg-white p-6 rounded-xl shadow-md border border-gray-100">
                        <div class="text-4xl text-amber-500 mb-4"><i class="fa-solid fa-fire"></i></div>
                        <h3 class="text-xl font-bold text-gray-800 mb-2">胰臟與肝臟 (Metabolism)</h3>
                        <ul class="text-sm text-gray-600 space-y-2 list-disc list-inside">
                            <li>促進胰島素依葡萄糖濃度分泌</li>
                            <li>抑制升糖素不當分泌</li>
                            <li>減少肝臟脂肪堆積與發炎</li>
                        </ul>
                    </div>
                    <!-- Organ 4 -->
                    <div class="card-hover bg-white p-6 rounded-xl shadow-md border border-gray-100">
                        <div class="text-4xl text-emerald-600 mb-4"><i class="fa-solid fa-heart-circle-check"></i></div>
                        <h3 class="text-xl font-bold text-gray-800 mb-2">心血管系統 (CV System)</h3>
                        <ul class="text-sm text-gray-600 space-y-2 list-disc list-inside">
                            <li>降低系統性發炎反應 (Anti-inflammation)</li>
                            <li>改善血管內皮功能</li>
                            <li>降低收縮壓與改善血脂</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- 2. 減重成效深度分析 (Weight Loss Deep Dive) -->
    <section id="weight" class="py-20 bg-accent/30">
        <div class="container mx-auto px-4 lg:px-8">
            <div class="text-center max-w-3xl mx-auto mb-16">
                <span class="text-secondary font-bold tracking-widest uppercase text-sm">EFFICACY DATA</span>
                <h2 class="text-3xl font-bold text-primary mt-2">減重成效：突破性的臨床數據</h2>
                <p class="text-gray-600 mt-4">
                    比較 Semaglutide 與新一代雙機轉藥物 Tirzepatide 在不同臨床試驗中的表現。
                </p>
            </div>

            <!-- Chart Container -->
            <div class="bg-white p-8 lg:p-12 rounded-3xl shadow-xl max-w-5xl mx-auto mb-12">
                <h3 class="text-xl font-bold text-gray-800 mb-8 border-b pb-4">平均體重減輕百分比 (68-72週)</h3>
                
                <!-- Chart Row 1: Placebo -->
                <div class="mb-8">
                    <div class="flex justify-between text-sm text-gray-600 mb-2">
                        <span>生活型態調整 (安慰劑組)</span>
                        <span class="font-bold">2.4% - 3.1%</span>
                    </div>
                    <div class="w-full bg-gray-100 rounded-full h-10 relative overflow-hidden">
                        <div class="bg-gray-400 h-full flex items-center px-4 text-white text-xs font-bold" style="width: 15%">
                            基礎對照
                        </div>
                    </div>
                </div>

                <!-- Chart Row 2: Semaglutide -->
                <div class="mb-8">
                    <div class="flex justify-between text-sm text-gray-600 mb-2">
                        <span class="flex items-center gap-2"><i class="fa-solid fa-syringe text-blue-500"></i> Semaglutide 2.4 mg (STEP 1)</span>
                        <span class="font-bold text-primary text-lg">-14.9%</span>
                    </div>
                    <div class="w-full bg-gray-100 rounded-full h-10 relative overflow-hidden">
                        <div class="gradient-bg h-full flex items-center px-4 text-white text-sm font-bold shadow-lg" style="width: 70%">
                            平均減重 15.3 kg
                        </div>
                    </div>
                    <p class="text-xs text-gray-500 mt-2 ml-1">註：約 86% 受試者體重減輕 >5%，超過 50% 受試者減輕 >15%。</p>
                </div>

                <!-- Chart Row 3: Tirzepatide -->
                <div class="mb-4">
                    <div class="flex justify-between text-sm text-gray-600 mb-2">
                        <span class="flex items-center gap-2"><i class="fa-solid fa-syringe text-purple-500"></i> Tirzepatide 15 mg (SURMOUNT-1)</span>
                        <span class="font-bold text-purple-700 text-lg">-20.9%</span>
                    </div>
                    <div class="w-full bg-gray-100 rounded-full h-10 relative overflow-hidden">
                        <div class="bg-gradient-to-r from-purple-600 to-purple-400 h-full flex items-center px-4 text-white text-sm font-bold shadow-lg" style="width: 90%">
                            平均減重 23.6 kg
                        </div>
                    </div>
                    <p class="text-xs text-gray-500 mt-2 ml-1">註：SURMOUNT-5 頭對頭研究顯示，Tirzepatide 減重幅度優於 Semaglutide。</p>
                </div>
            </div>

            <!-- Insight Box -->
            <div class="grid md:grid-cols-2 gap-8 max-w-5xl mx-auto">
                <div class="bg-white p-6 rounded-xl shadow-sm border-l-4 border-primary">
                    <h4 class="font-bold text-gray-800 mb-2">選擇 Semaglutide 的理由</h4>
                    <p class="text-sm text-gray-600 leading-relaxed">
                        雖然 Tirzepatide 在絕對減重數字上略勝一籌，但 Semaglutide 擁有目前最完整的<strong>長期安全性數據</strong>，以及經證實的<strong>心血管與腎臟保護適應症</strong>。對於合併有三高、心臟病史或腎臟風險的患者，Semaglutide 仍是首選。
                    </p>
                </div>
                <div class="bg-white p-6 rounded-xl shadow-sm border-l-4 border-purple-500">
                    <h4 class="font-bold text-gray-800 mb-2">選擇 Tirzepatide 的理由</h4>
                    <p class="text-sm text-gray-600 leading-relaxed">
                        對於<strong>BMI 極高 (>=35)</strong> 或使用單一機轉藥物效果停滯的患者，雙機轉的 Tirzepatide 能提供更強效的代謝調節與減重效果。其心血管長期預後試驗 (SURPASS-CVOT) 正在進行中。
                    </p>
                </div>
            </div>
        </div>
    </section>

    <!-- 3. 心血管與腎臟保護 (Cardio-Renal Protection) -->
    <section id="cv-renal" class="py-20 bg-white">
        <div class="container mx-auto px-4 lg:px-8">
            <div class="mb-12">
                <h2 class="text-3xl font-bold text-primary mb-4 border-l-8 border-secondary pl-4">超越體重：救命的器官保護效益</h2>
                <p class="text-gray-600 text-lg">肥胖是系統性疾病，Semaglutide 是目前少數證實能逆轉器官損傷的藥物。</p>
            </div>

            <div class="grid lg:grid-cols-2 gap-12">
                <!-- Cardiovascular Card -->
                <div class="group relative bg-slate-50 rounded-3xl overflow-hidden shadow-lg border border-slate-100">
                    <div class="absolute top-0 w-full h-2 bg-red-500"></div>
                    <div class="p-8">
                        <div class="flex items-center gap-4 mb-6">
                            <div class="w-16 h-16 bg-red-100 rounded-2xl flex items-center justify-center text-red-600 text-3xl">
                                <i class="fa-solid fa-heart-crack"></i>
                            </div>
                            <div>
                                <h3 class="text-2xl font-bold text-gray-800">心血管保護</h3>
                                <span class="text-xs font-bold text-white bg-red-500 px-2 py-1 rounded">SELECT Trial</span>
                            </div>
                        </div>
                        
                        <p class="text-gray-600 mb-6 text-justify">
                            針對 17,604 名<strong>無糖尿病</strong>但有心血管疾病史的過重/肥胖患者，追蹤長達 40 個月。結果證實 Semaglutide 不僅減重，更能直接保護心臟。
                        </p>

                        <div class="bg-white p-6 rounded-xl shadow-inner mb-6">
                            <div class="flex justify-between items-end mb-2">
                                <span class="text-gray-600 font-bold">MACE (重大心血管事件) 風險</span>
                                <span class="text-3xl font-bold text-red-600">-20%</span>
                            </div>
                            <div class="w-full bg-gray-100 h-2 rounded-full mb-4">
                                <div class="bg-red-500 h-2 rounded-full" style="width: 80%"></div>
                            </div>
                            <ul class="text-sm text-gray-500 space-y-1">
                                <li><i class="fa-solid fa-check text-red-500 mr-2"></i>降低心血管死亡</li>
                                <li><i class="fa-solid fa-check text-red-500 mr-2"></i>降低非致死性心肌梗塞</li>
                                <li><i class="fa-solid fa-check text-red-500 mr-2"></i>降低非致死性中風</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <!-- Renal Card -->
                <div class="group relative bg-slate-50 rounded-3xl overflow-hidden shadow-lg border border-slate-100">
                    <div class="absolute top-0 w-full h-2 bg-blue-500"></div>
                    <div class="p-8">
                        <div class="flex items-center gap-4 mb-6">
                            <div class="w-16 h-16 bg-blue-100 rounded-2xl flex items-center justify-center text-blue-600 text-3xl">
                                <i class="fa-solid fa-kidneys"></i>
                            </div>
                            <div>
                                <h3 class="text-2xl font-bold text-gray-800">腎臟保護</h3>
                                <span class="text-xs font-bold text-white bg-blue-500 px-2 py-1 rounded">FLOW Trial</span>
                            </div>
                        </div>
                        
                        <p class="text-gray-600 mb-6 text-justify">
                            針對 3,533 名<strong>第二型糖尿病合併慢性腎臟病 (CKD)</strong> 患者的研究。由於療效顯著優異，試驗提早終止。這是首個證明 GLP-1 RA 能預防腎衰竭的大型研究。
                        </p>

                        <div class="bg-white p-6 rounded-xl shadow-inner mb-6">
                            <div class="grid grid-cols-2 gap-4">
                                <div class="text-center border-r border-gray-100">
                                    <div class="text-3xl font-bold text-blue-600 mb-1">-24%</div>
                                    <div class="text-xs text-gray-500">重大腎臟疾病事件<br>(腎衰竭/死亡)</div>
                                </div>
                                <div class="text-center">
                                    <div class="text-3xl font-bold text-blue-600 mb-1">-20%</div>
                                    <div class="text-xs text-gray-500">全因死亡率<br>(All-cause mortality)</div>
                                </div>
                            </div>
                            <div class="mt-4 pt-4 border-t border-gray-100">
                                <div class="flex justify-between items-center text-sm">
                                    <span class="text-gray-600">eGFR 下降速度</span>
                                    <span class="text-blue-600 font-bold">顯著延緩 (每年少流失 1.16 ml/min)</span>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Liver (MASH) Update -->
            <div class="mt-12 bg-green-50 rounded-2xl p-8 border border-green-100 flex flex-col md:flex-row items-center gap-8">
                <div class="md:w-1/3 text-center md:text-left">
                    <div class="inline-block p-3 bg-green-100 text-green-700 rounded-full mb-4 text-2xl">
                        <i class="fa-solid fa-liver"></i>
                    </div>
                    <h3 class="text-xl font-bold text-gray-800">脂肪肝炎 (MASH) 新希望</h3>
                    <p class="text-sm text-gray-600 mt-2">ESSENCE 研究 (2025 最新數據)</p>
                </div>
                <div class="md:w-2/3 grid grid-cols-1 sm:grid-cols-2 gap-6">
                    <div class="bg-white p-4 rounded-lg shadow-sm">
                        <div class="text-3xl font-bold text-green-600 mb-1">62.9%</div>
                        <div class="text-sm text-gray-600">脂肪性肝炎獲得緩解<br><span class="text-xs text-gray-400">(且纖維化未惡化)</span></div>
                    </div>
                    <div class="bg-white p-4 rounded-lg shadow-sm">
                        <div class="text-3xl font-bold text-green-600 mb-1">36.8%</div>
                        <div class="text-sm text-gray-600">肝纖維化獲得改善<br><span class="text-xs text-gray-400">(且肝炎未惡化)</span></div>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- 4. 詳細比較表格 (Comparison Table) -->
    <section id="comparison" class="py-20 bg-gray-50">
        <div class="container mx-auto px-4 lg:px-8">
            <h2 class="text-3xl font-bold text-center text-primary mb-4">藥物綜合比較表</h2>
            <p class="text-center text-gray-600 mb-12 max-w-2xl mx-auto">
                針對您的具體狀況（是否合併糖尿病、是否有心血管病史），醫師會依據以下實證選擇最適合的藥物。
            </p>

            <div class="overflow-hidden rounded-2xl shadow-xl border border-gray-200 bg-white">
                <div class="overflow-x-auto">
                    <table class="w-full text-sm text-left">
                        <thead>
                            <tr class="bg-primary text-white">
                                <th class="p-5 min-w-[150px]">比較項目</th>
                                <th class="p-5 min-w-[200px] bg-blue-800">Semaglutide (Wegovy/Ozempic)</th>
                                <th class="p-5 min-w-[200px]">Tirzepatide (Zepbound/Mounjaro)</th>
                                <th class="p-5 min-w-[180px] bg-gray-600">Liraglutide (Saxenda)</th>
                            </tr>
                        </thead>
                        <tbody class="divide-y divide-gray-100">
                            <!-- Basic Info -->
                            <tr>
                                <td class="p-5 font-bold bg-gray-50 text-gray-700">藥物機轉</td>
                                <td class="p-5 bg-blue-50/30"><span class="font-bold text-primary">GLP-1 受體促效劑</span><br>單一機轉</td>
                                <td class="p-5"><span class="font-bold text-purple-700">GIP / GLP-1 雙重促效劑</span><br>雙重機轉 (Twincretin)</td>
                                <td class="p-5 text-gray-500">GLP-1 受體促效劑<br>(短效型)</td>
                            </tr>
                            <tr>
                                <td class="p-5 font-bold bg-gray-50 text-gray-700">使用頻率</td>
                                <td class="p-5 bg-blue-50/30 font-bold text-green-600">每週一次 (皮下注射)</td>
                                <td class="p-5 font-bold text-green-600">每週一次 (皮下注射)</td>
                                <td class="p-5 text-orange-500">每日一次 (皮下注射)</td>
                            </tr>
                            
                            <!-- Efficacy -->
                            <tr class="bg-gray-50/50">
                                <td class="p-5 font-bold bg-gray-50 text-gray-700">平均減重幅度<br><span class="text-xs font-normal text-gray-400">(非糖尿病人)</span></td>
                                <td class="p-5 bg-blue-50/30">
                                    <div class="text-xl font-bold text-gray-800">~15%</div>
                                    <div class="text-xs text-gray-500">STEP 1 Trial</div>
                                </td>
                                <td class="p-5">
                                    <div class="text-xl font-bold text-purple-700">~21%</div>
                                    <div class="text-xs text-gray-500">SURMOUNT-1 Trial</div>
                                    <span class="inline-block mt-1 text-[10px] bg-purple-100 text-purple-700 px-1 rounded">減重效果最強</span>
                                </td>
                                <td class="p-5 text-gray-500">
                                    <div>~8%</div>
                                    <div class="text-xs">SCALE Trial</div>
                                </td>
                            </tr>

                            <!-- Outcomes -->
                            <tr>
                                <td class="p-5 font-bold bg-gray-50 text-gray-700">心血管保護實證<br><span class="text-xs font-normal text-gray-400">(MACE Reduction)</span></td>
                                <td class="p-5 bg-blue-50/30">
                                    <span class="text-green-600 font-bold"><i class="fa-solid fa-check"></i> 已證實 (SELECT)</span>
                                    <p class="text-xs text-gray-600 mt-1">降低 20% 重大風險 (針對肥胖+CVD族群)</p>
                                </td>
                                <td class="p-5">
                                    <span class="text-yellow-600"><i class="fa-regular fa-clock"></i> 研究進行中</span>
                                    <p class="text-xs text-gray-500 mt-1">SURPASS-CVOT 預計 2025 後公佈</p>
                                </td>
                                <td class="p-5">
                                    <span class="text-green-600 font-bold"><i class="fa-solid fa-check"></i> 已證實 (LEADER)</span>
                                    <p class="text-xs text-gray-600 mt-1">針對糖尿病族群</p>
                                </td>
                            </tr>
                            <tr>
                                <td class="p-5 font-bold bg-gray-50 text-gray-700">腎臟保護實證<br><span class="text-xs font-normal text-gray-400">(CKD Outcomes)</span></td>
                                <td class="p-5 bg-blue-50/30">
                                    <span class="text-green-600 font-bold"><i class="fa-solid fa-check"></i> 已證實 (FLOW)</span>
                                    <p class="text-xs text-gray-600 mt-1">降低 24% 腎病惡化風險，FDA 已核准相關標示</p>
                                </td>
                                <td class="p-5">
                                    <span class="text-yellow-600"><i class="fa-regular fa-clock"></i> 次級分析顯示潛力</span>
                                    <p class="text-xs text-gray-500 mt-1">專屬腎臟試驗進行中</p>
                                </td>
                                <td class="p-5">
                                    <span class="text-gray-500">次級分析顯示效益</span>
                                </td>
                            </tr>
                            <tr>
                                <td class="p-5 font-bold bg-gray-50 text-gray-700">脂肪肝炎 (MASH)</td>
                                <td class="p-5 bg-blue-50/30">
                                    <span class="text-green-600 font-bold"><i class="fa-solid fa-check"></i> 顯著有效 (ESSENCE)</span>
                                    <p class="text-xs text-gray-600 mt-1">63% 緩解率</p>
                                </td>
                                <td class="p-5">
                                    <span class="text-green-600 font-bold"><i class="fa-solid fa-check"></i> 顯著有效 (SYNERGY)</span>
                                    <p class="text-xs text-gray-600 mt-1">62% 緩解率 (Phase 2)</p>
                                </td>
                                <td class="p-5 text-gray-400">數據較少</td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div class="p-4 bg-gray-100 text-xs text-gray-500 text-center">
                    註：所有藥物使用均需由醫師評估。表格數據來自不同臨床試驗，受試者條件可能不同，僅供科學參考。
                </div>
            </div>
        </div>
    </section>

    <!-- 5. 副作用管理 (Safety & Management) -->
    <section id="safety" class="py-20 bg-white">
        <div class="container mx-auto px-4 lg:px-8">
            <div class="flex flex-col lg:flex-row gap-12">
                <div class="lg:w-1/2">
                    <h2 class="text-3xl font-bold text-primary mb-6 border-l-8 border-secondary pl-4">副作用管理與安全須知</h2>
                    <p class="text-gray-600 mb-6">
                        GLP-1 藥物最常見的副作用來自於腸胃道反應（噁心、嘔吐、便秘、腹瀉），這通常是<strong>暫時性</strong>的，且多發生在剛開始使用或劑量增加時。
                    </p>
                    
                    <h4 class="font-bold text-gray-800 mb-3">如何緩解不適？醫師的實用建議：</h4>
                    <ul class="space-y-4">
                        <li class="flex items-start gap-3">
                            <div class="w-6 h-6 rounded-full bg-green-100 text-green-600 flex items-center justify-center flex-shrink-0 mt-1"><i class="fa-solid fa-utensils"></i></div>
                            <div>
                                <strong class="text-gray-800">細嚼慢嚥，少量多餐</strong>
                                <p class="text-sm text-gray-600">一旦覺得「不餓」就停止進食，不要吃到「飽」。避免過度撐大胃部引起噁心。</p>
                            </div>
                        </li>
                        <li class="flex items-start gap-3">
                            <div class="w-6 h-6 rounded-full bg-green-100 text-green-600 flex items-center justify-center flex-shrink-0 mt-1"><i class="fa-solid fa-ban"></i></div>
                            <div>
                                <strong class="text-gray-800">避免油膩與辛辣食物</strong>
                                <p class="text-sm text-gray-600">高油脂食物會進一步延緩胃排空，加重脹氣與噁心感。</p>
                            </div>
                        </li>
                        <li class="flex items-start gap-3">
                            <div class="w-6 h-6 rounded-full bg-green-100 text-green-600 flex items-center justify-center flex-shrink-0 mt-1"><i class="fa-solid fa-stairs"></i></div>
                            <div>
                                <strong class="text-gray-800">循序漸進的劑量調整</strong>
                                <p class="text-sm text-gray-600">嚴格遵守醫師指示，從低劑量開始（如 Semaglutide 0.25mg），每 4 週視情況調整。切勿急於求成。</p>
                            </div>
                        </li>
                    </ul>
                </div>
                <div class="lg:w-1/2">
                    <div class="bg-red-50 p-8 rounded-2xl border border-red-100">
                        <h3 class="text-xl font-bold text-red-800 mb-4"><i class="fa-solid fa-triangle-exclamation mr-2"></i>禁忌症與注意事項</h3>
                        <ul class="space-y-3 text-sm text-gray-700">
                            <li class="flex gap-2">
                                <i class="fa-solid fa-xmark text-red-500 mt-1"></i>
                                <span><strong>甲狀腺髓質癌 (MTC)</strong>：個人或家族病史者禁用。</span>
                            </li>
                            <li class="flex gap-2">
                                <i class="fa-solid fa-xmark text-red-500 mt-1"></i>
                                <span><strong>多發性內分泌腫瘤症候群第 2 型 (MEN 2)</strong>：患者禁用。</span>
                            </li>
                            <li class="flex gap-2">
                                <i class="fa-solid fa-xmark text-red-500 mt-1"></i>
                                <span><strong>懷孕與哺乳</strong>：備孕期間建議停藥至少 2 個月。</span>
                            </li>
                            <li class="flex gap-2">
                                <i class="fa-solid fa-circle-exclamation text-orange-500 mt-1"></i>
                                <span><strong>胰臟炎病史</strong>：需由醫師謹慎評估。</span>
                            </li>
                            <li class="flex gap-2">
                                <i class="fa-solid fa-circle-exclamation text-orange-500 mt-1"></i>
                                <span><strong>膽囊疾病</strong>：快速減重可能增加膽結石風險，如有嚴重腹痛需就醫。</span>
                            </li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- 6. 常見問題 (FAQ) - Expanded -->
    <section id="faq" class="py-20 bg-accent/30">
        <div class="container mx-auto px-4 lg:px-8 max-w-4xl">
            <h2 class="text-3xl font-bold text-center text-primary mb-12">常見問題 (FAQ)</h2>
            
            <div class="space-y-4">
                <details class="group bg-white rounded-xl p-6 shadow-sm cursor-pointer border border-gray-100">
                    <summary class="flex justify-between items-center font-bold text-gray-800 text-lg list-none">
                        <span>Q: 使用這類藥物會導致肌肉流失嗎？</span>
                        <span class="transition group-open:rotate-180 text-primary"><i class="fa-solid fa-chevron-down"></i></span>
                    </summary>
                    <div class="text-gray-600 mt-4 leading-relaxed pl-4 border-l-2 border-primary">
                        任何快速減重（包括手術或極低熱量飲食）都可能伴隨肌肉流失。臨床研究顯示，雖然總體重下降中包含部分瘦肉組織，但透過<strong>高蛋白飲食</strong>與<strong>規律的阻力訓練 (重訓)</strong>，可以顯著保留肌肉量。這也是為何我們強調「藥物+生活型態調整」缺一不可。
                    </div>
                </details>

                <details class="group bg-white rounded-xl p-6 shadow-sm cursor-pointer border border-gray-100">
                    <summary class="flex justify-between items-center font-bold text-gray-800 text-lg list-none">
                        <span>Q: 停藥後會復胖嗎？這藥需要打一輩子嗎？</span>
                        <span class="transition group-open:rotate-180 text-primary"><i class="fa-solid fa-chevron-down"></i></span>
                    </summary>
                    <div class="text-gray-600 mt-4 leading-relaxed pl-4 border-l-2 border-primary">
                        肥胖被醫學界定義為一種「慢性疾病」，如同高血壓或糖尿病。STEP 1 延伸研究顯示，停藥後若未維持飲食控制，體重確實有回升趨勢。建議將藥物視為幫助您建立新生活習慣的「浮板」，在用藥期間養成良好的飲食與運動習慣，即便未來減量或停藥，也能維持較好的成果。對於有嚴重心血管或代謝風險的患者，長期維持治療可能是保護器官的最佳策略。
                    </div>
                </details>

                <details class="group bg-white rounded-xl p-6 shadow-sm cursor-pointer border border-gray-100">
                    <summary class="flex justify-between items-center font-bold text-gray-800 text-lg list-none">
                        <span>Q: 什麼是 "Ozempic Face" (凹陷臉)？</span>
                        <span class="transition group-open:rotate-180 text-primary"><i class="fa-solid fa-chevron-down"></i></span>
                    </summary>
                    <div class="text-gray-600 mt-4 leading-relaxed pl-4 border-l-2 border-primary">
                        這並非藥物直接導致的皮膚病變，而是「快速大幅減重」後的自然現象。當臉部脂肪流失過快，皮膚可能來不及收縮而顯得鬆弛或凹陷。保持水份充足、營養均衡（特別是蛋白質），並避免體重下降過快（每週建議 0.5-1 公斤），可減少此現象發生。
                    </div>
                </details>

                <details class="group bg-white rounded-xl p-6 shadow-sm cursor-pointer border border-gray-100">
                    <summary class="flex justify-between items-center font-bold text-gray-800 text-lg list-none">
                        <span>Q: 手術前需要停藥嗎？</span>
                        <span class="transition group-open:rotate-180 text-primary"><i class="fa-solid fa-chevron-down"></i></span>
                    </summary>
                    <div class="text-gray-600 mt-4 leading-relaxed pl-4 border-l-2 border-primary">
                        是的。由於 GLP-1 藥物會延緩胃排空，可能增加麻醉時食物逆流吸入肺部的風險。美國麻醉醫學會建議，在進行擇期手術（需全身麻醉或深度鎮靜）前，每週施打的藥物（如 Semaglutide）應<strong>暫停一週</strong>（即手術前一週不要施打）。請務必告知您的麻醉醫師您正在使用此藥物。
                    </div>
                </details>
            </div>
        </div>
    </section>

    <!-- 頁尾 -->
    <footer class="bg-primaryDark text-white py-16">
        <div class="container mx-auto px-4 lg:px-8">
            <div class="grid md:grid-cols-2 lg:grid-cols-4 gap-12 mb-12">
                <div class="col-span-1 lg:col-span-2">
                    <div class="flex items-center gap-3 mb-6">
                        <div class="w-8 h-8 bg-white rounded-full flex items-center justify-center text-primary text-sm">
                            <i class="fa-solid fa-dna"></i>
                        </div>
                        <span class="font-bold text-xl">代謝醫學實證衛教網</span>
                    </div>
                    <p class="text-blue-200 text-sm leading-relaxed max-w-md">
                        致力於提供最前沿、基於實證醫學 (EBM) 的減重與代謝疾病治療資訊。我們相信，透過正確的知識，每個人都能找回健康的主控權。
                    </p>
                </div>
                <div>
                    <h4 class="font-bold mb-4 text-secondary">快速連結</h4>
                    <ul class="space-y-2 text-sm text-blue-200">
                        <li><a href="#mechanism" class="hover:text-white transition">作用機轉</a></li>
                        <li><a href="#weight" class="hover:text-white transition">減重成效數據</a></li>
                        <li><a href="#cv-renal" class="hover:text-white transition">心腎器官保護</a></li>
                        <li><a href="#safety" class="hover:text-white transition">安全性資訊</a></li>
                    </ul>
                </div>
                <div>
                    <h4 class="font-bold mb-4 text-secondary">聯絡我們</h4>
                    <ul class="space-y-2 text-sm text-blue-200">
                        <li class="flex items-center gap-2"><i class="fa-solid fa-phone"></i> 預約專線：07-1234-7788</li>
                        <li class="flex items-center gap-2"><i class="fa-brands fa-line"></i> LINE: @metabolic_health</li>
                        <li class="flex items-center gap-2"><i class="fa-solid fa-location-dot"></i> 高雄市買菜區...</li>
                    </ul>
                </div>
            </div>
            
            <div class="border-t border-blue-900 pt-8">
                <div class="text-xs text-blue-300 text-justify leading-relaxed space-y-4">
                    <p class="font-bold text-white">免責聲明與參考文獻說明：</p>
                    <p>
                        1. 本網頁內容僅供衛教參考，不能取代專業醫療建議、診斷或治療。Semaglutide (Ozempic®, Wegovy®)、Tirzepatide (Mounjaro®, Zepbound®) 等均為處方用藥，必須由醫師診斷後開立。
                    </p>
                    <p>
                        2. 數據來源參考：<br>
                        - Weight Loss: Wilding JPH et al. (STEP 1). NEJM 2021; Jastreboff AM et al. (SURMOUNT-1). NEJM 2022.<br>
                        - Head-to-Head: Aronne LJ et al. (SURMOUNT-5). [Publication pending/Conf data].<br>
                        - Cardiovascular: Lincoff AM et al. (SELECT). NEJM 2023.<br>
                        - Kidney: Perkovic V et al. (FLOW). NEJM 2024.<br>
                        - Liver (MASH): Newsome PN et al. (ESSENCE). [Latest Data].
                    </p>
                    <p>
                        3. 台灣藥品核准適應症可能與國際研究結果有所不同，實際處方請以衛福部核准之仿單為準。
                    </p>
                    <p class="text-center mt-8">&copy; 2025 代謝醫學實證衛教網. All Rights Reserved.</p>
                </div>
            </div>
        </div>
    </footer>

</body>
</html>